JP2018532100A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018532100A5 JP2018532100A5 JP2018506180A JP2018506180A JP2018532100A5 JP 2018532100 A5 JP2018532100 A5 JP 2018532100A5 JP 2018506180 A JP2018506180 A JP 2018506180A JP 2018506180 A JP2018506180 A JP 2018506180A JP 2018532100 A5 JP2018532100 A5 JP 2018532100A5
- Authority
- JP
- Japan
- Prior art keywords
- collection tube
- blood collection
- vacuum blood
- drug
- contact system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021109554A JP7242765B2 (ja) | 2015-08-13 | 2021-06-30 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
| JP2023035922A JP2023078232A (ja) | 2015-08-13 | 2023-03-08 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
| JP2024123778A JP7829634B2 (ja) | 2015-08-13 | 2024-07-30 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562204644P | 2015-08-13 | 2015-08-13 | |
| US62/204,644 | 2015-08-13 | ||
| US201562214308P | 2015-09-04 | 2015-09-04 | |
| US62/214,308 | 2015-09-04 | ||
| PCT/US2016/046681 WO2017027771A1 (en) | 2015-08-13 | 2016-08-12 | Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021109554A Division JP7242765B2 (ja) | 2015-08-13 | 2021-06-30 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018532100A JP2018532100A (ja) | 2018-11-01 |
| JP2018532100A5 true JP2018532100A5 (https=) | 2019-09-05 |
| JP6907188B2 JP6907188B2 (ja) | 2021-07-21 |
Family
ID=56802683
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018506180A Active JP6907188B2 (ja) | 2015-08-13 | 2016-08-12 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
| JP2021109554A Active JP7242765B2 (ja) | 2015-08-13 | 2021-06-30 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
| JP2023035922A Pending JP2023078232A (ja) | 2015-08-13 | 2023-03-08 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
| JP2024123778A Active JP7829634B2 (ja) | 2015-08-13 | 2024-07-30 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021109554A Active JP7242765B2 (ja) | 2015-08-13 | 2021-06-30 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
| JP2023035922A Pending JP2023078232A (ja) | 2015-08-13 | 2023-03-08 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
| JP2024123778A Active JP7829634B2 (ja) | 2015-08-13 | 2024-07-30 | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10870115B2 (https=) |
| EP (3) | EP3909509B1 (https=) |
| JP (4) | JP6907188B2 (https=) |
| KR (2) | KR102777762B1 (https=) |
| CN (2) | CN116196995A (https=) |
| AU (2) | AU2016306653B2 (https=) |
| BR (1) | BR112018002742B1 (https=) |
| CO (1) | CO2018002531A2 (https=) |
| EA (1) | EA201890478A1 (https=) |
| ES (1) | ES2938089T3 (https=) |
| IL (3) | IL295914B2 (https=) |
| MX (2) | MX2018001786A (https=) |
| WO (1) | WO2017027771A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6907188B2 (ja) | 2015-08-13 | 2021-07-21 | ダイアックス コーポレーション | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
| US11340237B2 (en) | 2016-09-16 | 2022-05-24 | Takeda Pharmaceutical Company Limited | Metabolite biomarkers for diseases associated with the contact activation system |
| EP4548103A2 (en) | 2022-06-30 | 2025-05-07 | Takeda Pharmaceutical Company Limited | Protein biomarkers for lanadelumab treatment |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047323A (en) | 1986-01-22 | 1991-09-10 | Temple University Of The Commonwealth System Of Higher Education | Method for detecting human kininogen using monoclonal antibodies thereto |
| WO1995021601A2 (en) | 1994-01-11 | 1995-08-17 | Protein Engineering Corporation | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
| JP3622286B2 (ja) * | 1995-09-01 | 2005-02-23 | 日東紡績株式会社 | α２ −プラスミンインヒビタ−の測定方法及び測定試 薬 |
| US5789261A (en) * | 1996-10-30 | 1998-08-04 | Temple University Of The Commonwealth System Of Higher Education | Solid phase immunoassay |
| SK12572001A3 (sk) * | 1999-03-15 | 2002-03-05 | Takeda Chemical Industries, Ltd. | Proteín, peptid, protilátka, spôsob výroby a farmaceutický prostriedok |
| JP4496407B2 (ja) | 2002-05-13 | 2010-07-07 | ベクトン・ディキンソン・アンド・カンパニー | プロテアーゼ阻害剤試料採取システム |
| SE0202880D0 (sv) * | 2002-07-26 | 2002-09-30 | Wieslab Ab | Complement system deficiency assay |
| US8603345B2 (en) * | 2003-02-13 | 2013-12-10 | Becton, Dickinson And Company | Devices for component removal during blood collection, and uses thereof |
| US7138412B2 (en) | 2003-03-11 | 2006-11-21 | Bristol-Myers Squibb Company | Tetrahydroquinoline derivatives useful as serine protease inhibitors |
| US20050124965A1 (en) * | 2003-12-08 | 2005-06-09 | Becton, Dickinson And Company | Phosphatase inhibitor sample collection system |
| WO2005084317A2 (en) * | 2004-03-01 | 2005-09-15 | Board Of Regents, The University Of Texas System | Dimeric small molecule potentiators of apoptosis |
| EP1828152B1 (en) | 2004-12-08 | 2008-08-20 | Bristol-Myers Squibb Company | Heterocyclic compounds as inhibitors of factor viia |
| US20060183771A1 (en) | 2005-02-17 | 2006-08-17 | Seiffert Dietmar A | Novel combination of selective factor VIIa and/or factor XIa inhibitors and selective plasma kallikrein inhibitors |
| US9957569B2 (en) * | 2005-09-12 | 2018-05-01 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
| ES2336622T3 (es) | 2006-06-06 | 2010-04-14 | F. Hoffmann-La Roche Ag | Recipiente de recogida de sangre total lista para usar. |
| EP1890155A1 (en) * | 2006-08-17 | 2008-02-20 | F. Hoffmann-Roche AG | Methods and means for determining platelet function and diagnosing platelet-related and cardiovascular disorders |
| US20080286818A1 (en) * | 2007-05-18 | 2008-11-20 | Datwyler Saul A | Blood sample handling methods for improved assays for myeloperoxidase |
| JP2010528647A (ja) * | 2007-06-06 | 2010-08-26 | ドマンティス リミテッド | ポリペプチド、抗体可変ドメインおよびアンタゴニスト |
| WO2009022001A1 (en) * | 2007-08-16 | 2009-02-19 | Novartis Ag | Improvement of drug tolerance in immunogenicity testing |
| WO2009026539A1 (en) * | 2007-08-23 | 2009-02-26 | Genzyme Corporation | Treatment with kallikrein inhibitors |
| US8283160B2 (en) * | 2007-09-11 | 2012-10-09 | Frey Ii William H | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| US9482677B2 (en) | 2008-02-27 | 2016-11-01 | Scios Inc. | Method, composition and device for sampling natriuretic peptides in a biological fluid |
| US7985188B2 (en) | 2009-05-13 | 2011-07-26 | Cv Holdings Llc | Vessel, coating, inspection and processing apparatus |
| WO2011024172A2 (en) * | 2009-08-27 | 2011-03-03 | Technion Research & Development Foundation Ltd. | Liposomal compositions and uses of same |
| WO2011033046A1 (en) | 2009-09-18 | 2011-03-24 | Probiodrug Ag | Novel assay for the detection of amyloid beta peptides |
| CN102740888B (zh) * | 2009-11-24 | 2016-10-12 | 奥尔德生物制药公司 | Il-6抗体及其用途 |
| NZ609363A (en) | 2010-10-18 | 2015-04-24 | Nestec Sa | Methods for determining anti-drug antibody isotypes |
| KR102320178B1 (ko) * | 2011-01-06 | 2021-11-02 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 결합 단백질 |
| CA2828761C (en) | 2011-03-04 | 2017-04-04 | Becton, Dickinson And Company | Blood collection device containing lysophospholipase inhibitor |
| JP6189754B2 (ja) * | 2011-03-04 | 2017-08-30 | イントレキソン コーポレーション | タンパク質を条件的に発現するベクター |
| US9352016B2 (en) * | 2011-03-09 | 2016-05-31 | Csl Behring Gmbh | Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces |
| GB201114017D0 (en) | 2011-08-15 | 2011-09-28 | Univ Dundee | Inhibitors against endosomal/ysosomal enzymes |
| BR112014018970A8 (pt) * | 2012-02-02 | 2017-07-11 | Becton Dickinson Co | Dispositivos de coleta de amostra com agentes de estabilização sanguínea |
| RU2015136025A (ru) | 2013-02-01 | 2017-03-06 | Бектон, Дикинсон энд Кампани | Устройства для сбора крови, содержащие добавки, ингибирующие контактный путь свертывания крови |
| CA2916399C (en) | 2013-06-28 | 2022-08-02 | Marc Nolte | Combination therapy using a factor xii inhibitor and a c1-inhibitor |
| WO2015061183A1 (en) | 2013-10-21 | 2015-04-30 | Dyax Corp. | Assays for determining plasma kallikrein system biomarkers |
| JP6907188B2 (ja) * | 2015-08-13 | 2021-07-21 | ダイアックス コーポレーション | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
-
2016
- 2016-08-12 JP JP2018506180A patent/JP6907188B2/ja active Active
- 2016-08-12 CN CN202211657332.8A patent/CN116196995A/zh active Pending
- 2016-08-12 KR KR1020187007140A patent/KR102777762B1/ko active Active
- 2016-08-12 EP EP21168520.1A patent/EP3909509B1/en active Active
- 2016-08-12 MX MX2018001786A patent/MX2018001786A/es unknown
- 2016-08-12 EP EP25168791.9A patent/EP4574040A3/en active Pending
- 2016-08-12 BR BR112018002742-1A patent/BR112018002742B1/pt active IP Right Grant
- 2016-08-12 IL IL295914A patent/IL295914B2/en unknown
- 2016-08-12 IL IL311909A patent/IL311909B2/en unknown
- 2016-08-12 EP EP16757774.1A patent/EP3334343B1/en active Active
- 2016-08-12 AU AU2016306653A patent/AU2016306653B2/en active Active
- 2016-08-12 IL IL257209A patent/IL257209B/en unknown
- 2016-08-12 ES ES16757774T patent/ES2938089T3/es active Active
- 2016-08-12 KR KR1020257007061A patent/KR20250035045A/ko active Pending
- 2016-08-12 CN CN201680047254.6A patent/CN108135547B/zh active Active
- 2016-08-12 US US15/752,228 patent/US10870115B2/en active Active
- 2016-08-12 EA EA201890478A patent/EA201890478A1/ru unknown
- 2016-08-12 WO PCT/US2016/046681 patent/WO2017027771A1/en not_active Ceased
-
2018
- 2018-02-12 MX MX2022014713A patent/MX2022014713A/es unknown
- 2018-03-09 CO CONC2018/0002531A patent/CO2018002531A2/es unknown
-
2020
- 2020-11-24 US US17/102,509 patent/US11458477B2/en active Active
-
2021
- 2021-06-30 JP JP2021109554A patent/JP7242765B2/ja active Active
- 2021-08-13 AU AU2021215261A patent/AU2021215261B2/en active Active
-
2022
- 2022-08-23 US US17/821,681 patent/US11826758B2/en active Active
-
2023
- 2023-03-08 JP JP2023035922A patent/JP2023078232A/ja active Pending
-
2024
- 2024-07-30 JP JP2024123778A patent/JP7829634B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Haschke et al. | Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects | |
| EP3551046B1 (en) | Gastrointestinal tract detection methods, devices and systems | |
| JP2018532100A5 (https=) | ||
| CN115475171B (zh) | 一种具有抗冠状病毒活性的化合物及其应用 | |
| CN105683760A (zh) | 用于诊断原发性醛甾酮增多症的方法 | |
| JP2016519311A5 (https=) | ||
| WO2008011193A2 (en) | Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders | |
| WO2014001574A8 (en) | Method for diagnosing invasive candida infections | |
| JP2019532633A5 (https=) | ||
| JP2019502095A5 (https=) | ||
| JP2023078232A (ja) | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 | |
| Liu et al. | Inhibition of cIAP1/2 reduces RIPK1 phosphorylation in pulmonary endothelial cells and alleviate sepsis-induced lung injury and inflammatory response | |
| IL312919B1 (en) | Peptide assay to distinguish between full-length high molecular weight kinogen (HMWK) and cleaved HMWK | |
| WO2012078752A8 (en) | Serine protease inhibitor kazal antibodies | |
| García‐Gimenez et al. | Circulating histones as clinical biomarkers in critically ill conditions | |
| Zhong et al. | Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis | |
| Devani et al. | Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers | |
| CN103185710B (zh) | 人静脉注射免疫球蛋白中活化凝血因子ⅺ检测方法 | |
| Hardt et al. | Surveying proteolytic processes in human cancer microenvironments by microdialysis and activity‐based mass spectrometry | |
| 陳克耀 et al. | Serological survey of equine piroplasmosis, equine granulocytic anaplasmosis, and equine Lyme disease in Taiwan | |
| US20250288542A1 (en) | Methods and compositions to treat and prevent viral infections and acute respiratory distress syndrome | |
| Patel et al. | DEVELOPMENT AND VALIDATION OF AN ACCURATE AND PRECISE LC-MS/MS METHOD FOR DETERMINATION OF TENOFOVIR AND EMTRICITABINE IN HUMAN PLASMA. | |
| JP2019529906A5 (https=) | ||
| CN103837630B (zh) | 一种病人血液中百草枯的快速检测方法 | |
| CN102268422B (zh) | 一种可抑制hiv-1反转录酶的蝉花蛋白酶及制备方法 |